Gilead Sciences as of March 31, 2025
Portfolio Holdings for Gilead Sciences
Gilead Sciences holds 14 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 37.3 | $441M | 6.7M | 65.60 | |
| Galapagos Nv Spon Adr (GLPG) | 35.5 | $419M | 17M | 25.10 | |
| Arcus Biosciences Incorporated (RCUS) | 20.9 | $247M | 31M | 7.85 | |
| Assembly Biosciences Com New (ASMB) | 1.8 | $21M | 2.2M | 9.56 | |
| Merus N V (MRUS) | 1.6 | $19M | 453k | 42.09 | |
| Kyverna Therapeutics (KYTX) | 0.7 | $8.0M | 4.1M | 1.93 | |
| Tango Therapeutics (TNGX) | 0.6 | $6.7M | 4.9M | 1.37 | |
| Xilio Therapeutics (XLO) | 0.6 | $6.6M | 9.1M | 0.72 | |
| Kalaris Therapeutics (KLRS) | 0.5 | $5.8M | 723k | 8.03 | |
| Hookipa Pharma Com New (HOOK) | 0.2 | $2.0M | 1.9M | 1.08 | |
| Allogene Therapeutics (ALLO) | 0.1 | $1.7M | 1.2M | 1.46 | |
| Leap Therapeutics Com New (LPTX) | 0.1 | $1.6M | 5.3M | 0.31 | |
| Ikena Oncology (IKNA) | 0.1 | $1.5M | 1.2M | 1.28 | |
| Barinthus Biotherapeutics Pl Ads (BRNS) | 0.0 | $360k | 370k | 0.97 |
